FL
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Multicenter, Single-Arm Exploratory Phase I Clinical Study (Assessment of Safety and Efficacy) of Fully Human BAFF-R Chimeric Antigen Receptor T-Cell Injection in Relapsed/Refractory BAFF-R-Positive B-Cell Lymphoma (NCT07259070) | Institute of Hematology & Blood Diseases Hospital, China | 2025-11-29 |
| Zanubrutinib and G-CHOP in Untreated Intermediate-high Risk Follicular Lymphoma (NCT06474481) | Tianjin Medical University Cancer Institute and Hospital | 2024-07-01 |
| First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma (NCT03625037) | Genmab | 2018-06-26 |
Track FL automatically
Every clearance here is in the API, with alerts when new ones post.